Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-950-7 | CAS number: 187393-00-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- February 19, 1997 through April 4, 1997
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- RCC Holding Company Ltd.; 4414 Füllinsdorf, Switzerland
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Study was performed before LLNA was formally validated and available as OECD guideline in 2002.
Test material
- Details on test material:
- - Name of test material (as cited in study report): CFG-C-1607
- Physical state: yellow solid
- Analytical purity: >98%
- Lot/batch No.: 002
- Expiration date of the lot/batch: 31 Aug 1998
- Stability under test conditions: stable in PEG 400 for at least 48 hours
- Storage condition of test material: in the original container at room temperature away from direct sunlight
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Himalayan
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: BRL, Biological Research Laboratories Ltd., Wolferstrasse 4, CH-4414 Fullinsdorf / Switzerland
- Age at study initiation: 5 - 7 weeks
- Weight at study initiation: 328 - 406 g
- Housing: Individually in Makrolon type-3 cages with standard softwood bedding ("Lignocel", Schill AG, CH-4132 Muttenz)
- Diet (e.g. ad libitum): Pelleted standard Nafag Ecosan 845 25W4, batch nos. 01/97 and 10/97 guinea pig breeding 1 maintenance diet ("Nafag II , Nahr- und Futtermittel AG, CH-9202 Gossau), ad libitum.
- Water (e.g. ad libitum): Community tap water from Itingen, ad libitum. Once weekly additional supply of ascorbic acid (approx. 1 gil) via the drinking water was provided.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 40-70 %
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12-hour light, 12-hour dark cycle
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Concentration / amount:
- 3%
- Route:
- epicutaneous, occlusive
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Concentration / amount:
- 30%
- Day(s)/duration:
- 48h
- Adequacy of induction:
- other: Non irritant test substance but animals were pretreated with 10% SLS
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- polyethylene glycol
- Remarks:
- PEG 400
- Concentration / amount:
- 30%
- Day(s)/duration:
- 24h
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 5 animals in control group, 10 animals in test group, 1 animal in intradermal pretest, 2 animals in epidermal pretest
- Details on study design:
- RANGE FINDING TESTS:
A pretest was performed during the acclimatization period. The concentrations tested were for the epicutaneous application to assure an optimum technical application procedure and for the intracutaneous injection the selected concentrations were tested up to 5 % (intradermal) and up to 30% (epicutaneous).
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epidermal)
- Test groups: Intradermal induction: 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline, test article diluted to 3% with PEG 400, the test article diluted to 3% by emulsion in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline; Epidermal induction: 30%
- Control group: Intradermal induction: 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline, PEG 400, 1:1 (w/w) mixture of PEG 400 in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline; Epidermal induction: PEG 400
- Site: dorsal skin in the scapular region
- Frequency of applications: intradermal injection once on day 1 and epidermal application once on day 8
- Duration:epidermal application for 48 hours
- Concentrations: 3% in intradermal injection and 30% in epicutaneous application
B. CHALLENGE EXPOSURE
- No. of exposures: one epidermal exposure
- Day(s) of challenge: Day 22
- Exposure period: challenge was two weeks after the epidermal induction application for 24h.
- Test groups: 30% and PEG 400
- Control group: 30% and PEG 400
- Site: left and right flank of each guinea pig
- Concentrations:30%
- Evaluation (hr after challenge): 24 hours and 48 hours after removal of the dressing - Challenge controls:
- - Control group: 30% and PEG 400
- Positive control substance(s):
- yes
- Remarks:
- alpha-hexylcinnamaldehyde
Results and discussion
- Positive control results:
- In this study 70 % of the animals of the positive control group were observed with positive skin reactions after treatment of the positive control in 25 % polyethylene glycol (PEG 400). No skin reactions were observed in the control group.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 30% in PEG 400
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 30% in PEG 400
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 25% in PEG 400
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25% in PEG 400
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- vehicle
- No. with + reactions:
- 0
- Total no. in group:
- 5
Any other information on results incl. tables
As there were no deaths during the course of the treatment period no necropsies were performed.
No symptoms of systemic toxicity were observed in the animals.
The body weight of the animals was within the range of physiological variability known for this strain and age.
Pretest:
Table 1. Reaction Readings from intradermal injection - Pretest.
Animal No. |
Sex |
Concentration (%) |
Reaction Readings after 24 hours |
||
Erythema |
Oedema |
Diameter (mm) |
|||
552 |
M |
5 |
1 |
1 |
7 x 7 |
|
|
3 |
1 |
1 |
7 x 7 |
|
|
1 |
1 |
1 |
7 x 8 |
Table 2. Reactions from epidermal application - Pretest.
Animal No. |
Sex |
Concentration (%) |
Reaction Readings after Removal of Bandage |
|||
After 24 hours |
After 48 hours |
|||||
E |
Oe |
E |
Oe |
|||
553 |
M |
30 |
0 |
0 |
0 |
0 |
25 |
0 |
0 |
0 |
0 |
||
15 |
0 |
0 |
0 |
0 |
||
10 |
0 |
0 |
0 |
0 |
||
554 |
M |
10 |
0 |
0 |
0 |
0 |
30 |
0 |
0 |
0 |
0 |
||
25 |
0 |
0 |
0 |
0 |
||
15 |
0 |
0 |
0 |
0 |
E = Erythema
Oe = Oedema
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Conclusions:
- In this study 0 % of the animals of the test group were observed with positive skin reactions after treatment with a non-irritant test article concentration of 30 % in PEG 400. No skin reactions were observed in the control group. Therefore, the test article CGF-C-1607 applied at a concentration of 30 % in PEG 400 is considered not to be a sensitizer when used under the described test conditions.
- Executive summary:
In order to assess the cutaneous allergenic potential of CGF-C-1607, the Maximization-Test in accordance with OECD Guideline No. 406 and the Directive 96/54IEEC, B.6 was carried out in 15 (10 test and 5 control) male Himalayan guinea pigs. The intradermal induction of sensitization was carried out with a 3 % dilution of the test article in PEG 400 and in an emulsion with Freund's Complete Adjuvant (FCA) / physiological saline. The epicutaneous induction of sensitization was conducted under occlusion with the test article at 30 % in PEG 400. Two weeks after the epicutaneous induction application the challenge was completed by epicutaneous application of the test article at 30 % in PEG 400 under occlusive dressing. The animals of the control group were induced with PEG 400 and FCA/physiological saline and challenged similarly as those of the test group. Cutaneous reactions, i.e. erythema and eschar, as well as oedema formation were evaluated at 24 and 48 hours after removal of the dressing. No toxic symptoms were evident in the guinea pigs of the control or test group. No deaths occurred. In this study 0 % of the animals of the test group were observed with positive skin reactions after treatment with a non-irritant test article concentration of 30 % in PEG 400. No skin reactions were observed in the control group.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.